Experience

Blueprint Medicines

• United States
• Biotechnology Research
• 400 - 500 Employee

• Area Business Manager

  • Jan 2023 - Present



ADC Therapeutics

• Switzerland
• Biotechnology Research
• 200 - 300 Employee

• Hematology Therapeutic Specialist

  • Jan 2021 - Dec 2022



Dova Pharmaceuticals

• United States
• Biotechnology
• 1 - 100 Employee

• Senior Territory Manager

  • Jul 2019 - Dec 2020



TESARO, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Area Manager

  • Aug 2015 - Jul 2019

  Develop/Educate Oncology treating community in CINV prevention and treatment for new unique product. Develop/Educate Oncology treating community in CINV prevention and treatment for new unique product.



Bayer

• Chemical Manufacturing
• 700 & Above Employee

• Oncology Specialty Consutant

  • Jan 2014 - Jul 2015

  METASTATIC COLORECTAL, G.I.S.T., PROSTATE, LIVER, KIDNEY, THYROID, tumor types and varying oncologic disease states. METASTATIC COLORECTAL, G.I.S.T., PROSTATE, LIVER, KIDNEY, THYROID, tumor types and varying oncologic disease states.



ARIAD Pharmaceuticals, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Oncology Account Specialist

  • Oct 2012 - Nov 2013

  Senior Hematology/Oncology Account Specialist-Boston North • Successfully launched Iclusig (oral TKI), within the CML market. • Worked closely with Specialty Pharmacies and Distributors. • Successfully met launch goal in first year. • Exceeded forecasted potential for territory launch to date. Senior Hematology/Oncology Account Specialist-Boston North • Successfully launched Iclusig (oral TKI), within the CML market. • Worked closely with Specialty Pharmacies and Distributors. • Successfully met launch goal in first year. • Exceeded forecasted potential for territory launch to date.



Eisai US

• Pharmaceutical Manufacturing
• 700 & Above Employee

• District Sales Manager

  • Jan 2010 - Jun 2011

  New England-(Promotion) · Consistent 30 % growth average for District goals quarter over previous quarter YTD. · 4th out of 25 districts in nation in YTD Portfolio % growth parameter. -Started 18th out of 25 districts in Q1=60% Portfolio growth parameter. · 118% Portfolio goal attainment last measurable quarter. Responsibilities- 1. Motivate team to establish, grow and promote product portfolio in New … Show more New England-(Promotion) · Consistent 30 % growth average for District goals quarter over previous quarter YTD. · 4th out of 25 districts in nation in YTD Portfolio % growth parameter. -Started 18th out of 25 districts in Q1=60% Portfolio growth parameter. · 118% Portfolio goal attainment last measurable quarter. Responsibilities- 1. Motivate team to establish, grow and promote product portfolio in New England in Oncology / Hematology clinics and the hospital setting. 2. Educate team to utilize all available resources of company and execute upon targeted educational, clinical goals of territory. 3. Present at all district, regional, national meetings. 4. Attend and represent company at National /Regional symposia for Oncology / Hematology disease states. i.e. NNECOS, NERON, CCE, ASCO. 5. Recruit and Hire New members of sales team and regional sales force.

• National Field Trainer (Promotion)

  • Jan 2009 - Jan 2010

  (Promotion -Management) · Additional responsibilities of training both new and experienced Sales professionals in the field to deliver high impact messaging. · Train New Hire classes in house on Oncology/Hematology portfolio. · Maintain responsibilities of sales for territory.



MGI Pharma

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Territory Manager (Promotion)

  • Feb 2006 - Jan 2009

  Educate and promote Boston North territory Hematology/ Oncology treating institutions on disease state management of MDS, and chemotherapeutic anti-emetics. Educate and promote Boston North territory Hematology/ Oncology treating institutions on disease state management of MDS, and chemotherapeutic anti-emetics.



InterMune

• Biotechnology
• 1 - 100 Employee

• Clinical Specialist

  • Apr 2004 - Dec 2005

  · Adopted"... one of the worst performing territories in the nation." according to 2004 review. · Received EXCEEDS EXPECTATIONS on latest review. · 2005 Current MATTY rank 15th in nation. Ranked 62nd in 04/04. · 439% rolling 12 month growth for HCV. · 743% growth DDD and direct data sales. · Recipient of Q/4 REGIONAL SALES/ LEADERSHIP AWARD. · Adopted"... one of the worst performing territories in the nation." according to 2004 review. · Received EXCEEDS EXPECTATIONS on latest review. · 2005 Current MATTY rank 15th in nation. Ranked 62nd in 04/04. · 439% rolling 12 month growth for HCV. · 743% growth DDD and direct data sales. · Recipient of Q/4 REGIONAL SALES/ LEADERSHIP AWARD.



Roche Laboratories

• Specialist (Promotion)

  • Nov 2000 - Apr 2004

  Educate and promote The key medical/educational institutions in down town Boston on cutting edge Hepatitis C therapy. Had responsibility of all medical institutions in the city of Boston both hospitals and clinics that treated HCV. Educate and promote The key medical/educational institutions in down town Boston on cutting edge Hepatitis C therapy. Had responsibility of all medical institutions in the city of Boston both hospitals and clinics that treated HCV.



Abbott

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Medical Representative

  • Mar 1997 - Nov 2000

  Southern NH ­ Southern ME · Successfully launched two new products into competitive markets. · Opened three OPAT centers in Territory, one in each section of territory North, South, and Central. · Promoted to MR status from PPR. · Won first or second place for three consecutive months of "Xenical Power Program". · Chairman for "FLAMES RIDE" A.D.A. Fundraiser, had significant impact on territory. Southern NH ­ Southern ME · Successfully launched two new products into competitive markets. · Opened three OPAT centers in Territory, one in each section of territory North, South, and Central. · Promoted to MR status from PPR. · Won first or second place for three consecutive months of "Xenical Power Program". · Chairman for "FLAMES RIDE" A.D.A. Fundraiser, had significant impact on territory.